Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Lymphoma, Large B-Cell, Diffuse × Lenalidomide × Clear all

Status

Completed 24 Unknown 16 Active not recruiting 16 Recruiting 15 Terminated 10 Not yet recruiting 3 Withdrawn 2 Suspended 1 Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1

Interventions

fludarabine 1 Rituximab 1 R-CHOP protocol 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Leukapheresis 1 Lenalidomide 1 Decitabine 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05690191 2023-01-19

Chidamide in Patients With Recurrent and Refractory Diffuse Large b

Second Affiliated Hospital of Soochow University

Enrolling by invitation

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡